Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1989-06-06
1990-05-08
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142368, 5142375, 544131, 544137, 544141, 544162, 544167, A61K 31535, C07D26530, C07D41306
Patent
active
049238639
ABSTRACT:
Compounds are disclosed of formula (I): ##STR1## wherein R.sub.1 and R.sub.2 are the same or different and are C.sub.1-6 alkyl or C.sub.3-6 alkenyl; or --NR.sub.1 R.sub.2 forms a 5-membered (optionally containing an oxygen atom adjacent to the nitrogen) or a 6-membered ring, which ring optionally contains one unit of unsaturation and which is unsubstituted or substituted by hydroxy, oxo, optionally substituted methylidene, --COR.sub.3 (where R.sub.6 represents C.sub.1-6 alkyl, OR.sub.4 or --NHR.sub.4, and R.sub.4 represents hydrogen, C.sub.1-6 alkyl, aryl, ar(C.sub.1-6)alkyl) or .dbd.NOR.sub.5 (where R.sub.5 represents C.sub.1-6 alkyl);
REFERENCES:
patent: 2428239 (1947-09-01), Parker et al.
patent: 3586713 (1971-06-01), Buu-Hoi et al.
Bays David E.
Scopes David I. C.
Glaxo Group Limited
Ramsuer Robert W.
LandOfFree
Morpholine derivatives, pharmaceutical compositions and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Morpholine derivatives, pharmaceutical compositions and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Morpholine derivatives, pharmaceutical compositions and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2349333